wide may reduce the present delay between the initiation of a search for an unrelated donor and actual transplantation that occurs using existing unrelated marrow donor panels.
Cord blood has become an acceptable source of haematopoIn our present study, we have used a triple bag system ietic marrow repopulating stem cells. A variety of maligin which the cord blood is separated by centrifugation into nant and non-malignant haematological diseases have been three components: a buffy coat, a red cell and a plasma treated using transplanted cord blood but the total number fraction. This method of processing allowed for mainteof transplants performed remains small.
1,2 The best use of nance of sterility, volume reduction and separation of red umbilical cord blood is likely to come when cord blood blood cells and some granulocytes from buffy coat progenibanks are established with large numbers of HLA typed tor cells. samples stored ready for prompt use in unrelated recipients. This usage has recently been initiated by the New York group who have transplanted 25 patients with unrelated cord blood transplants.
2 Expansion of this procedure world-
Materials and methods

Informed consent
Correspondence: Dr AM Dickinson, Department of Haematology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne,
The collection of cord blood was performed in the depart- calf serum, sodium bicarbonate, pyruvate, glutamine and growth factors (erythropoietin (Boehringer Mannheim, Lewes, UK) 1.5 units/ml, recombinant granulocyte colonystimulating factor (rG-CSF) 1000 units/ml and stem cell Separation of cord blood and nucleated cell counts factor (SCF) at 20 ng/ml). Both rG-CSF and SCF were gifts from Amgen, Cambridge, UK. Plates were incubated at Twenty-five donations collected into triple bags were separ-37°C in humidified 5% carbon dioxide in 95% air. Granuloated by centrifugation at 4400 g for 18.5 min at 22°C using cyte-macrophage colonies (CFU-GM), haemoglobinised a Heraeus Cryofuge 8000 (Heraeus Instruments Ltd, Brent-(BFU-e) colonies, and mixed erythroid/myeloid colonies wood, UK). The method described for separation of the (CFU-GEMM) containing greater than 40 cells were cord blood is a modification of that originally described by scored on day 14. In 17 MNC samples the total number Hö gman et al 11 for peripheral blood component preparation of colonies (CFU-GM, CFU-GEMM and BFU-e) per 10 5 and storage. After centrifugation, the supernatant plasma cells plated and percentage CD34 + were assessed and and sedimented red cells were expressed by the Baxter correlated. The results are expressed as total colonies in Optipress system (Baxter Health Care) into an upper and cord blood cells harvested based on the mononuclear lower plasma bag and red cell bag, respectively, leaving cell count. the buffy layer in the original collection bag. The WBC, CD34 and progenitor estimations were repeated on the buffy coat fraction. A full blood count was performed on the red cell fraction and an aerobic and anaerobic bacteriBacteriology ology screen was performed on the buffy coat fraction.
Erythrocyte, leucocyte and platelet counts were perfor-0.5 ml from each cord blood collection and from the buffy coat fraction after processing triple bag donations was med using an automated cell counter (Coulter STKS, Coulter Electronics Ltd, Luton, UK). In order to correct for the transferred to aerobic and anaerobic blood culture bottles Bactec 6A, and 7A respectively (Becton Dickinson). These presence in the cord blood of nucleated red cells, a manual white cell differential count was made on all samples. The bottles were then incubated at 37°C for 7 days. Positive cultures identified by measurement of CO 2 production were results were expressed as corrected total nucleated cell then gram stained and plated onto agar plates to confirm
Triple bag separation of whole cord blood bacterial or fungal identity.
The cord blood volume collected and used for the triple bag separation (n = 25) ranged from 44 ml to 133 ml (mean 81 ± 4.29 ml). 3.04 ± 0.39 × 10 6 (range 0.57-6.69 × 10 6 ). The CD34-posinucleated cell counts tive cell count obtained from the buffy fraction ranged from 0.55 × 10 6 to 7.9 × 10 6 (mean 3.05 ± 0.43 × 10 6 ) recovery The mean volume of cord blood collected from 201 100% (Table 1) . donations was 56.6 ± 2 ml (range 20-187 ml). During this
The red cell fraction was assessed for WBC content and period when midwives were being trained in collection was shown to have 1% or less of the original total nucleated techniques, 10% of all samples were Ͻ30 ml.
cell count. The final separated buffy coat volume ranged The mean total nucleated cell counts of all samples was from 28 to 60 ml (mean = 44 ml). 8.12 ± 0.34 × 10 8 and this result correlated with the volume Nineteen cord blood units were assessed for progenitor collected (Figure 1 ) (r = 0.81, P = 0.001). The incidence of cell content before and after separation ( Table 2 ). The mean bacterial contamination was 24 in 201 (11.9%) samples total progenitor content (CFU-GM, BFU-e and CFUtested which mainly consisted of skin flora; Staphylococcus GEMM) based on the mononuclear cell count was albus (n = 5), Streptococci (n = 6), Bacteroides (n = 4), 8.85 × 10 5 per collection before separation and 7.81 × 10 5 Diphtheroid (n = 4), Klebsiella (n = 1), Pseudomonas after separation. The initial mean total CFU-GM count was (n = 1), E. coli (n = 1) and Bacillus (n = 2). Although there 3.31 ± 0.60 × 10 5 per collection based on the total monowas a trend towards low volumes of cord blood collected nuclear cell count. After separation the mean CFU-GM being contaminated, using 2 analysis there was no signififrom the buffy coat fraction was 2.82 ± 0.64 × 10 5 with a cant correlation (P = 0.17) between low volumes of cord mean recovery of 85%. The lowest total CFU-GM content collected (Ͻ40 ml) and bacterial contamination (data not recovered was 0.9 × 10 5 and the highest 12.3 × 10 5 . shown).
The initial mean BFU-e content was 4.48 ± 0.85 × 10 5 Twenty-five samples were collected using the triple bag per collection and post-separation the BFU-e content was method and 1/25 (4%) demonstrated bacterial contami-4.09 ± 0.93 × 10 5 per collection; recovery 91.3%. Similarly nation.
CFU-GEMM recoveries following the separation procedure were excellent (pre 1.06 ± 0.34 × 10 5 ; post 0.9 ± 0.40 × 10 5 ; recovery 84.9%).
In a parallel study using a MNC fraction following separation of whole cord blood (n = 17) over lymphoprep (Nycomed) we assessed the units for total progenitor cell content and percentage of CD34-positive cells. This analysis demonstrated a correlation of coefficient of 0.63 (P = 0.01) Figure 2 .
Discussion
The increasing use of umbilical cord blood for bone marrow reconstitution after myeloablative chemotherapy means that banks with large numbers of cryopreserved cord blood progenitor cells to enable engraftment. A system was = total CD34-positive cells in each cord blood unit.
Table 2
Progenitor cell content in whole cord blood and buffy coat following triple bag separation of r = 0.63 was found (P = 0.01).
The mean volume collected using the triple bag collection system (81 ± 4.2 ml) was similar to that recently reported by others using a single collection bag.
2, 16 The collected. 18 Our studies observed a correlation between CFU-GM and CD34-positive cell numbers which was nucleated cell counts (10.53 ± 0.63 × 10 8 ) and CD34-positive cell counts (3.04 ± 0.39 × 10 6 ) were also similar to within the range reported by others for CB, 19 but not as high as one original paper by Fritsch et al 20 which may be those reported from other centres worldwide. 4, 8, 16, 17 The nucleated cell counts significantly correlated with the voldue to differences in culture techniques. Kurtzberg et al 2 have recently described results using cord blood for transume of cord blood collected, and this result is in agreement with other studies suggesting that the CFU-GM and CD34-plantation into unrelated recipients and stated that the number of nucleated cells transfused per kilogram body weight positive cell counts also correlate positively with volume correlated with the rate of myeloid engraftment (P = 0.002) coat. We aim to use this triple bag system for collection of cord blood for banking in our region. and that the nucleated cell dose may be a more important indicator of engraftment than CD34-positive cell or CFU-GM numbers.
Our results, which show similar nucleated cell recovery to that obtained from bone marrow processed by centrifugAcknowledgements ation, 21 
